1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Nanoparticle Tracking Analyzer Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising need to develop and commercialize novel targeted therapeutics
5.1.1.2. Growing focus on nanotechnology research
5.1.1.3. Elevating environmental concerns that require better pollutant detection methods
5.1.2. Restraints
5.1.2.1. Relatively high cost of nanotechnology equipment
5.1.3. Opportunities
5.1.3.1. Technological advancements in nanoparticle analyzer requiring minimal sample
5.1.3.2. Proliferating investment in research and development activities by governments and private organizations
5.1.4. Challenges
5.1.4.1. Difficulties in measuring broader size range of nanoparticles
5.2. Market Segmentation Analysis
5.2.1. Type: Proliferating demand for consumables
5.2.2. Application: Significant penetration of NTAs in drug delivery & targeting
5.2.3. Distribution: Emergence of nanoparticle tracking analyzers (NTAs) on online platforms
5.2.4. End-Use: Expanding applications of nanoparticle tracking analyzers (NTAs) in pharmaceutical & biotechnology companies
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Nanoparticle Tracking Analyzer Market, by Type
6.1. Introduction
6.2. Consumables
6.3. Instruments
7. Nanoparticle Tracking Analyzer Market, by Application
7.1. Introduction
7.2. Drug Delivery & Targeting
7.3. Exosome & Microvesicle Research
7.4. Protein Aggregation
7.5. Virology & Vaccine Development
8. Nanoparticle Tracking Analyzer Market, by Distribution
8.1. Introduction
8.2. Online Stores
8.3. Special Stores
9. Nanoparticle Tracking Analyzer Market, by End-Use
9.1. Introduction
9.2. Academic Research Institutions
9.3. Pharmaceutical & Biotechnology Companies
10. Americas Nanoparticle Tracking Analyzer Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Nanoparticle Tracking Analyzer Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Nanoparticle Tracking Analyzer Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
13.3.1. Agreement, Collaboration, & Partnership
13.3.1.1. Sartorius Forms Partnership with SPARTA Biodiscovery on Novel Nanoparticle Analysis Platform
13.3.1.2. NurExone and Particle Metrix Announce Collaboration in Extracellular Vesicles Analysis Using State-of-the-art Analytic Device
13.3.2. New Product Launch & Enhancement
13.3.2.1. Machine learning powers Malvern Panalytical’s new NanoSight Pro
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Agilent Technologies, Inc.
14.1.2. Analytik Ltd.
14.1.3. ATA Scientific Pty Ltd.
14.1.4. Beckman Coulter Inc.
14.1.5. BioCat GmbH
14.1.6. Bruker Corporation
14.1.7. Cell Guidance Systems LLC
14.1.8. Cellarcus Biosciences, Inc.
14.1.9. Coriolis Pharma Research GmbH
14.1.10. DKSH Management Ltd.
14.1.11. Hitachi Ltd.
14.1.12. HORIBA, Ltd.
14.1.13. Microtrac, Inc.
14.1.14. OleiniTec Nordic AB
14.1.15. Particle Metrix GmbH
14.1.16. Quark Photonics
14.1.17. Shimadzu Corporation
14.1.18. Spectris PLC
14.1.19. Sympatec GmbH
14.1.20. TSI Inc.
14.1.21. Wyatt Technology Corporation
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer